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Abstract: An important epigenetic modification is the methylation/demethylation of histone lysine
residues. The first histone demethylase to be discovered was a lysine-specific demethylase 1, LSD1,
a flavin containing enzyme which carries out the demethylation of di- and monomethyllysine 4 in his-
tone H3. The removed methyl groups are oxidized to formaldehyde. This reaction is similar to those
performed by dimethylglycine dehydrogenase and sarcosine dehydrogenase, in which protein-bound
tetrahydrofolate (THF) was proposed to serve as an acceptor of the generated formaldehyde. We
showed earlier that LSD1 binds THF with high affinity which suggests its possible participation in the
histone demethylation reaction. In the cell, LSD1 interacts with co-repressor for repressor element 1
silencing transcription factor (CoREST). In order to elucidate the role of folate in the demethylating
reaction we solved the crystal structure of the LSD1–CoREST–THF complex. In the complex, the
folate-binding site is located in the active center in close proximity to flavin adenine dinucleotide. This
position of the folate suggests that the bound THF accepts the formaldehyde generated in the course
of histone demethylation to form 5,10-methylene-THF. We also show the formation of 5,10-methyl-
ene-THF during the course of the enzymatic reaction in the presence of THF by mass spectrometry.
Production of this form of folate could act to prevent accumulation of potentially toxic formaldehyde
in the cell. These studies suggest that folate may play a role in the epigenetic control of gene expres-
sion in addition to its traditional role in the transfer of one-carbon units in metabolism.
Keywords: LSD1; tetrahydrofolate; crystal structure; epigenetics
Abbreviations: CoREST, co-repressor for repressor element 1 silencing transcription factor; diMeK4H31–21, dimethyl-Lys4 His-
tone H3 peptide aa1–21; DMGDH, dimethylglycine dehydrogenase; FAD, flavin adenine dinucleotide; LSD1, lysine specific his-
tone demethylase 1; monoMeK4H31–21, monomethyl-Lys4 Histone H3 peptide aa1–21; SDH, sarcosine dehydrogenase; THF,
tetrahydrofolate.
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Introduction
One of the most important recent discoveries in epige-
netics was the identification of the enzymes that
remove methyl groups, which serve as epigenetic
markers, from lysine residues of histones.1–5 Demethy-
lation of mono- and dimethylated Lys4 on histone H3 is
catalyzed by lysine specific demethylase 1 (LSD1). This
enzyme is an amine oxidase containing flavin adenine
dinucleotide (FAD) as the electron acceptor to first oxi-
dize the lysine N-methyl amine to lysine N-methyli-
mine. FADH2 is reoxidized to FAD by molecular oxygen
producing hydrogen peroxide. The N-methylimine is
non-enzymatically hydrolyzed to a carbinolamine
which spontaneously dissociates to a demethylated
lysine and formaldehyde (Supporting Information Fig.
S1). If the substrate is a dimethylated Lys4 the enzyme
performs sequential removal of both methyl groups by
the same mechanism. This mechanism is similar to
demethylation of dimethylglycine by dimethylglycine
dehydrogenase (DMGDH), sarcosine by sarcosine
dehydrogenase (SDH), and other similar enzymes.6,7
Both DMGDH and SDH bind tetrahydrofolate (THF).
This was proposed to serve as a trap for toxic formalde-
hyde by formation of methylene-tetrahydrofolate (5,10-
CH2-THF) non-enzymatically. Based upon the similar-
ity of reactions catalyzed by LSD1, DMGDH, and SDH,
we proposed that LSD1 could also bind THF. In our
previous publication we showed that, indeed, LSD1
binds THF with high affinity.8
In the cell, LSD1 demethylates histone H3 as part
of a multimeric protein complex in which it directly
interacts with the co-repressor of the repressor ele-
ment 1 silencing transcription factor, CoREST. Inter-
action of these two proteins has been studied in detail
and the crystal structure of the complex containing an
analog of the histone H3 peptide was determined.9,10
To elucidate the role of folate in histone H3 demethyla-
tion by LSD1 we have solved the crystal structure of
the complex of LSD1–CoREST–THF and determined
the folate binding site in LSD1.
Results
Folate-binding site
The overall structure of the LSD1–CoREST–THF com-
plex as shown in Figure 1(A) is essentially the same as
previously determined crystal structures of the LSD1–
CoREST and LSD1–CoREST with a substrate-like pep-
tide.9,10 In the complex, LSD1 interacts with CoREST
via its helix-tower without conformational changes in
other protein domains. The THF-binding site in the
crystal structure is located in the active center of LSD1
in close proximity to FAD in the amino oxidase domain.
Folate protein interactions and conformation
of folate
Folates, in complexes with proteins, can exist in dif-
ferent (bent or extended) conformations depending
on the specific folate–protein interactions.11–13 In
the LSD1–CoREST–THF complex, THF is observed
in the bent conformation with the p-aminobenzoic
(PABA) ring almost stacked to the pterin part of the
molecule [Fig. 1(B)]. As in other folate-binding pro-
teins, the THF is buried in the hydrophobic part of
the protein. The pterin and PABA rings interact
with the globular part of the protein. The glutamate
part of folate is mostly oriented toward the surface
of the protein. The hydrophobic interactions of THF
with the protein are established through most of the
atoms of the pterin and PABA rings with FAD,
Val333, Phe538, Tyr761, and Ala809. THF is located
3.56 Å from the FAD. In addition to the non-specific
hydrophobic interactions, THF establishes two
hydrogen bonds with LSD1: between the N5 of the
NH-group of the pterin ring and the carbonyl oxygen
of Ala539 (3.09 Å) and the glutamate moiety (OX2)
and ND1 of His564 (2.94 Å). There is also close sepa-
ration (3.27 Å) between nitrogen N2 atom of the
pterin ring and the OE1 oxygen of the glutamate
moiety of the folate [Fig. 2(A), drawn by Ligplot14].
In summary, the position of THF in the active center
of LSD1 is consistent with the proposed role of THF
as an acceptor of the one-carbon unit derived from
removed methyl group.
The position of THF in the active center of
LSD1 suggests its direct participation in the deme-
thylation reaction. It is not possible to determine the
exact positions of THF and the natural peptide sub-
strate in the active center without the reaction tak-
ing place. However, the crystal structure of LSD1–
CoREST with an inactive mutated 21-amino acid N-
terminal peptide of histone H3 in which Lys4 was
substituted with methionine has been solved (ref.
10, PDB ID 2V1D). Superposition of the folate bind-
ing site with this structure shows that folate occu-
pies the site of the Met in the substrate analogue
[Fig. 2(B)]. Because it is not possible for both THF
and the substrate to bind in exactly the same posi-
tion we believe that the structure determined by
Forneris et al.10 using the inactive substrate ana-
logue is not the native conformation. The mutated
peptide of histone H3 binds with the LSD1–CoREST
complex with much higher affinity (a lower Kd) than
the normal peptide10 and should result in a slight
change in conformation around the active site. This
suggests that the natural Lys4-peptide is positioned
in the active center in a different conformation than
the mutated peptide and that THF and the natural
peptide substrate are located in close proximity.
LSD1 activity in the presence of THF and 5,10-
CH2-THF formation
To check the possible role of THF as activator/inhibi-
tor, we used mass spectrometry to monitor the dis-
appearance of the diMeK4H31–21 substrate and the
formation of two demethylation products,
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monoMeK4H31–21 and unmethylated K4H31–21 with-
out and with THF in the reaction mixture. We found
that at the concentration employed, THF had no
effect on the time course of the concentrations of
substrate, mono-methylated product, or completely
demethylated product [Fig. 2(C)].
Use of mass-spectrometry allowed us to confirm
the conversion of THF to 5,10-CH2-THF during the
demethylation reaction. Spectral data acquired at
the 10 min reaction time point with and without
THF [Fig. 2(D)] reveals an additional ion with
[M1H]1 m/z 458.2 in the presence of THF that cor-
responds to 5,10-CH2-THF.
Discussion
In our work, we determined the position of the THF-
binding site in LSD1 which provides the basis for
understanding the role of THF in the histone H3
demethylation reaction. When studied in vitro, the
reaction products formaldehyde and hydrogen perox-
ide are formed. These compounds are potentially
toxic and should be neutralized by intracellular
detoxification mechanisms.
The formaldehyde generated could be scavenged
by THF which non-enzymatically reacts with formal-
dehyde and the product of this reaction is 5,10-CH2-
THF.15,16 Therefore, if free formaldehyde is released
in the course of histone demethylation it could be
trapped by this non-enzymatic reaction with THF.
In this case, THF should be bound to LSD1 in prox-
imity to the active center. This is exactly what we
found in the crystal structure of the LSD1–CoR-
EST–THF complex.
The 5,10-CH2-THF formed by reaction of formal-
dehyde with THF could be used for intracellular
metabolism. As discussed previously,8 one such path-
way for thymidylate synthase exists in the nucleus
in which 5,10-CH2-THF is used for synthesis of
deoxythymidine monophosphate (dTMP).17 It would
be reasonable to suggest that 5,10-CH2-THF synthe-
sized by oxidative demethylation of the histone H3
might be used as a substrate for thymidylate syn-
thase as well.
Figure 1. A: Overall structure of LSD1–CoREST–THF complex. LSD1 (green), CoREST (orange), FAD (blue), and THF (red) are
drawn in Pymol. N- and C-termini of the proteins are marked. B: A stereo view of the folate binding site in the LSD1–CoREST
complex. The Fo 2 Fc electron density map is contoured at 3r. The map was calculated before inclusion of the folate atoms
into the model. Superimposed final model of the LSD1–CoREST complex is shown. Hydrogen bonds are indicated by dashes.
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An important conclusion to be made from these
results is the role that folate may play in the epige-
netic control of gene expression. It suggests that this
group of coenzymes has a significance beyond the
traditional role as a carrier of one-carbon units.
Materials and Methods
All general chemicals and microbiological media
were from Sigma. Dimethyl-Lys4 Histone H3 peptide
aa 1–21 (diMeK4H31–21) was from BPS Bioscience.
PreScission protease was from GE Healthcare.
The natural (6S)-stereoisomer of tetrahydrofolate
monoglutamate ((6S)-THF-Glu1) was a gift from
EPROVA (Switzerland). The plasmids for the N-
terminal truncated LSD1 (aa 171–852) and CoREST
(aa 286–482 plus His-tag sequence) were a generous
gift of Dr. Cole (Johns Hopkins University). The
plasmid for full-size LSD1 expression was a gener-
ous gift of Dr. Shi (Harvard University).
The full size and truncated LSD1 were
expressed in E. coli BL21(DE3) as we reported in
the previous publication.8 CoREST was expressed in
E. coli BL21(DE3) in LB media with kanamycin (50
mg/mL) overnight at 19C with 1 mM isopropy1-D-1-
Figure 2. A: THF–protein interactions. Interactions of THF with LSD1 were analyzed by Ligplot and are presented in the soft-
ware drawing. Atoms participating in hydrogen bonding are connected with dashed lines with the distance in Å. The protein
residues participating in hydrophobic interaction are shown with Ligplot drawing for such interactions. B: Superposition of THF
and substrate model in the LSD1–CoREST–THF complex. The crystal structure from this work and that from PDB ID 2V1D were
superpositioned and folate (red), FAD molecules (blue and magenta), and model peptide (green with Met4 in blue) were drawn
by Pymol. C: LSD1 activity and formation of 5,10-CH2-THF in the course of demethylation reaction. Time course of LSD1 sub-
strate diMeK4H31–21 (black lines) and two products of reaction, monoMeK4H31–21 (red lines) and unmethylated K4H31–21 (blue
lines). The solid lines denote data for reaction without THF and dashed lines denote the data for reaction with THF. D: Forma-
tion of 5,10-CH2-THF. On the upper panel the mass spectrum of the 51 charge state of diMeK4H31–21 acquired for the 10 min
time point of the reaction without (green line) and with (red line) THF in reaction mixture. Note an appearance of the ion with m/
z 458.2, which corresponds to 5,10-CH2-THF. The peaks with m/z 457 are 51 charge state of diMeK4H31–21.
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thiogalactopyranoside (IPTG). Collected cells were
sonicated in the homogenization buffer 0.1M Tris,
pH 7.5, 2 mg/mL leupeptin, 2 mg/mL pepstatin, and 2
mM phenylmethylsulfonyl fluoride (PMSF) and
crude extract was obtained by centrifugation. The
crude extract was loaded onto column with Ni-NTA
resin (QIAGEN), and non-bound proteins were
washed-out with washing buffer containing 0.1M
Tris, pH 7.5, 0.5M NaCl, 2 mg/mL leupeptin, 2 mg/
mL pepstatin, 2 mM PMSF, and 20 mM imidazole.
Bound proteins were eluted with elution buffer 50
mM Tris, pH 7.5, and 250 mM imidazole. Eluted
proteins were concentrated and applied onto column
with Whatman CM-52 cellulose equilibrated with 20
mM Tris, pH 7.6, 5 mM b-mercaptoethanol. After
column washing with equilibration buffer, the CoR-
EST was eluted by 20 mM Tris pH 7.5, 1M NaCl
with purity greater than 95%.
Crystallization of LSD1–CoREST complex
The purpose of this work was to identify the folate-
binding site in the LSD1. Our preliminary crystalli-
zation trial showed that the best way to do this was
by using truncated LSD1 (which binds THF) com-
plexed with CoREST. The LSD1–CoREST complex
was prepared by mixing the LSD1 and CoREST stock
solutions in a 1:1.5 molar ratio of LSD to CoREST.
After incubating the mixture on ice for 1 h the solu-
tion conditions were changed to that used for crystal-
lization 10–12 mg/mL proteins concentration in 25
mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic
acid (HEPES)-Na, pH 7.4, 100 mM NaCl, 5 mM DTT,
1 mM PMSF and the excess CoREST was removed by
using an Amicon Ultra 50K concentrator.
The LSD1–CoREST complex was crystallized by
the sitting drop method at room temperature in the
conditions described earlier,9 with small adjustment
of the salts concentrations. The LSD1–CoREST com-
plex was mixed with the reservoir solution contain-
ing 0.60M Li2SO4, 0.63M (NH4)2SO4, 0.25M NaCl,
100 mM Na-citrate, pH 5.6, and 10 mM DTT. The
crystals of the LSD1–CoREST complex appeared in
one or two days and grew to the maximum dimen-
sions in 4–6 days. The crystals belong to the ortho-
rhombic I222 space group with a 5 123.86 Å,
b 5 179.37 Å, c 5 235.05 Å.
The THF ligand was introduced into the crystals
by the soaking method. The LSD1–CoREST complex
crystals were incubated for 3 h in the cryoprotectant
containing 0.76M Li2SO4, 0.74M (NH4)2SO4, 0.35M
NaCl, 100 mM Na-citrate, pH 5.6, 22 mM DTT, 23%
(vol/vol) glycerol, and 10 mM THF. After soaking the
crystals were flash-cooled in liquid nitrogen.
Data collection, structure solution, and
refinement
X-ray diffraction data were collected at 100 K at LS-
CAT beamline 21, Advanced Photon Source, Argonne
National Laboratory, IL using a MAR 225 CCD
detector. Data were processed and scaled using
HKL2000 package.18 Data collection and data proc-
essing statistics are summarized in Table I.
The molecular replacement procedure was
applied to locate a solution using the program MOL-
REP.19 The structure of the LSD1–CoREST complex
(PDB accession code 2IW5) was used as a search
model. The positioned MR model was refined using
the maximum likelihood refinement in REFMAC
with the TLS parameters generated by the TLSMD
server.19,20 The difference Fourier map revealed the
presence of (6S)-THF in the active site of the com-
plex [Fig. 1(B)]. The folate molecule was modeled
according to the shape of electron density. Coot was
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1
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c (%) 19.59/21.73























Ii, where Ii is the intensity of the






jFoj, where Fo and Fc are the
observed and calculated structure factors amplitudes. Rfree
is calculated using 5.1% of reflections omitted from the
refinement.
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used for model building throughout the refine-
ment.21 The final model consists of residues 171–836
of LSD1, residues 308–440 of CoREST, one FAD mol-
ecule, one folate molecule, one chloride anion, one
glycerol molecule, and 19 water molecules. Refine-
ment statistics are listed in Table I.
Monitoring reaction time course and measuring
formation of 5,10-CH2-THF by mass-
spectrometry
To monitor the reaction time course the substrate
diMeK4H31–21 peptide was demethylated in a 100 mL
reaction mixture containing 5 mM HEPES(Na), pH
7.5, 1.0 mM of LSD1, 42 mM of substrate, and 12.5 mM
of DTT with or without 250 mM of THF and levels of
substrate and products analyzed by mass-
spectrometry. Reaction mixture without substrate was
pre-incubated with THF for 30 min at 25C for protein-
ligand binding when the effect of THF was studied.
Atomic Coordinates
The data were deposited to Protein Data Bank with
PDB ID 4KUM.
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